Global Ophthalmic Devices & Drugs Market 2026 - Players, Regions, Product Types, Application & Forecast Analysis

Chapter 1 Ophthalmic Devices & Drugs Market Overview

1.1 Ophthalmic Devices & Drugs Definition

1.2 Global Ophthalmic Devices & Drugs Market Size Status and Outlook (2019-2032)

1.3 Global Ophthalmic Devices & Drugs Market Size Comparison by Region (2019-2032)

1.4 Global Ophthalmic Devices & Drugs Market Size Comparison by Type (2019-2032)

1.5 Global Ophthalmic Devices & Drugs Market Size Comparison by Application (2019-2032)

1.6 Global Ophthalmic Devices & Drugs Market Size Comparison by Sales Channel (2019-2032)

1.7 Ophthalmic Devices & Drugs Market Dynamics

1.7.1 Market Drivers/Opportunities

1.7.2 Market Challenges/Risks

1.7.3 Market News (Products Launch, Mergers, Acquisitions, Expansion, Agreement and Collaborations, Partnerships)

1.7.4 COVID-19 Impacts

1.7.5 Russia-Ukraine War Impacts

1.7.6 US-Israel-Iran War Impacts

Chapter 2 Executive Summary

2.1 Global Ophthalmic Devices & Drugs Market Snapshot

2.2 Global Ophthalmic Devices & Drugs Market Volume & Revenue (2019-2025)

2.3 Global Ophthalmic Devices & Drugs Market Differential Growth Potential Analysis by Type, (2019-2032) (USD Million)

2.4 Global Ophthalmic Devices & Drugs Market Differential Growth Potential Analysis by Application, (2019-2032) (USD Million)

2.5 Global Ophthalmic Devices & Drugs Market Differential Growth Potential Analysis by Sales Channels, (2019-2032) (USD Million)

2.6 Global Ophthalmic Devices & Drugs Market Differential Growth Potential Analysis by Region, (2019-2032) (USD Million)

Chapter 3 Ophthalmic Devices & Drugs Market Segment Analysis by Player

3.1 Global Ophthalmic Devices & Drugs Sales and Market Share by Player (2023-2025)

3.2 Global Ophthalmic Devices & Drugs Revenue and Market Share by Player (2023-2025)

3.3 Global Ophthalmic Devices & Drugs Average Price by Player (2023-2025)

3.4 Players Competition Situation & Trends (2023-2025)

3.5 Conclusion of Segment by Player

Chapter 4 Ophthalmic Devices & Drugs Market Segment Analysis by Type

4.1 Global Ophthalmic Devices & Drugs Market by Type

4.1.1 Ophthalmic Devices

4.1.2 Ophthalmic Drugs

4.2 Global Ophthalmic Devices & Drugs Sales and Market Share by Type (2019-2025)

4.3 Global Ophthalmic Devices & Drugs Revenue and Market Share by Type (2019-2025)

4.4 Global Ophthalmic Devices & Drugs Average Price by Type (2019-2025)

4.5 Leading Players of Ophthalmic Devices & Drugs by Type in 2025

4.6 Conclusion of Segment by Type

Chapter 5 Ophthalmic Devices & Drugs Market Segment Analysis by Application

5.1 Global Ophthalmic Devices & Drugs Market by Application

5.1.1 Glaucoma

5.1.2 Cataract

5.1.3 Age-Related Macular Degeneration

5.1.4 Inflammatory Diseases

5.1.5 Refractive Disorders

5.2 Global Ophthalmic Devices & Drugs Revenue and Market Share by Application (2019-2025)

5.3 Leading Consumers of Ophthalmic Devices & Drugs by Application in 2025

5.4 Conclusion of Segment by Application

Chapter 6 Ophthalmic Devices & Drugs Market Segment Analysis by Sales Channel

6.1 Global Ophthalmic Devices & Drugs Market by Sales Channel

6.1.1 Global Ophthalmic Devices & Drugs Market, by Direct Channel Market Analysis (2019-2032) (USD Million)

6.1.2 Global Ophthalmic Devices & Drugs Market, by Distribution Channel Market Analysis (2019-2032) (USD Million)

6.2 Global Ophthalmic Devices & Drugs Revenue and Market Share by Sales Channel (2019-2025)

6.3 Leading Distributors/Dealers of Ophthalmic Devices & Drugs by Sales Channel in 2025

6.4 Conclusion of Segment by Sales Channel

Chapter 7 Ophthalmic Devices & Drugs Market Segment Analysis by Region

7.1 Global Ophthalmic Devices & Drugs Market Size and CAGR by Region (2019-2032)

7.2 Global Ophthalmic Devices & Drugs Sales and Market Share by Region (2019-2025)

7.3 Global Ophthalmic Devices & Drugs Revenue and Market Share by Region (2019-2025)

7.4 North America

7.4.1 North America Market by Country

7.4.2 North America Ophthalmic Devices & Drugs Market Share by Type

7.4.3 North America Ophthalmic Devices & Drugs Market Share by Application

7.4.4 United States

7.4.5 Canada

7.4.6 Mexico

7.5 Europe

7.5.1 Europe Market by Country

7.5.2 Europe Ophthalmic Devices & Drugs Market Share by Type

7.5.3 Europe Ophthalmic Devices & Drugs Market Share by Application

7.5.4 Germany

7.5.5 United Kingdom

7.5.6 France

7.5.7 Italy

7.5.8 Russia

7.5.9 Spain

7.5.10 Benelux

7.5.11 Poland

7.5.12 Austria

7.5.13 Portugal

7.5.14 Rest of Europe

7.6 Asia-Pacific

7.6.1 Asia-Pacific Market by Country

7.6.2 Asia-Pacific Ophthalmic Devices & Drugs Market Share by Type

7.6.3 Asia-Pacific Ophthalmic Devices & Drugs Market Share by Application

7.6.4 China

7.6.5 Japan

7.6.6 Korea

7.6.7 India

7.6.8 Southeast Asia

7.6.9 Australia

7.6.10 Taiwan

7.6.11 Rest of Asia Pacific

7.7 South America

7.7.1 South America Market by Country

7.7.2 South America Ophthalmic Devices & Drugs Market Share by Type

7.7.3 South America Ophthalmic Devices & Drugs Market Share by Application

7.7.4 Brazil

7.7.5 Argentina

7.7.6 Colombia

7.7.7 Chile

7.7.8 Peru

7.7.9 Venezuela

7.7.10 Rest of South America

7.8 Middle East & Africa

7.8.1 Middle East & Africa Market by Country

7.8.2 Middle East & Africa Ophthalmic Devices & Drugs Market Share by Type

7.8.3 Middle East & Africa Ophthalmic Devices & Drugs Market Share by Application

7.8.4 UAE

7.8.5 Saudi Arabia

7.8.6 South Africa

7.8.7 Egypt

7.8.8 Nigeria

7.9.9 Rest of Middle East & Africa

7.9 Conclusion of Segment by Region

Chapter 8 Profile of Leading Ophthalmic Devices & Drugs Players

8.1 Bausch + Lomb

8.1.1 Company Snapshot

8.1.2 Product/Service Offered

8.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.1.4 Recent Developments

8.2 Pfizer

8.2.1 Company Snapshot

8.2.2 Product/Service Offered

8.2.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.2.4 Recent Developments

8.3 Bayer

8.3.1 Company Snapshot

8.3.2 Product/Service Offered

8.3.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.3.4 Recent Developments

8.4 Allergan

8.4.1 Company Snapshot

8.4.2 Product/Service Offered

8.4.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.4.4 Recent Developments

8.5 Novartis

8.5.1 Company Snapshot

8.5.2 Product/Service Offered

8.5.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.5.4 Recent Developments

8.6 HOYA

8.6.1 Company Snapshot

8.6.2 Product/Service Offered

8.6.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.6.4 Recent Developments

8.7 Essilor

8.7.1 Company Snapshot

8.7.2 Product/Service Offered

8.7.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.7.4 Recent Developments

8.8 Ziemer Ophthalmic Systems

8.8.1 Company Snapshot

8.8.2 Product/Service Offered

8.8.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.8.4 Recent Developments

8.9 Carl Zeiss Meditec

8.9.1 Company Snapshot

8.9.2 Product/Service Offered

8.9.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.9.4 Recent Developments

8.10 Aerie Pharmaceuticals

8.10.1 Company Snapshot

8.10.2 Product/Service Offered

8.10.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.10.4 Recent Developments

8.11 Alcon

8.11.1 Company Snapshot

8.11.2 Product/Service Offered

8.11.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.11.4 Recent Developments

8.12 Genentech

8.12.1 Company Snapshot

8.12.2 Product/Service Offered

8.12.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.12.4 Recent Developments

8.13 Haag-Streit

8.13.1 Company Snapshot

8.13.2 Product/Service Offered

8.13.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.13.4 Recent Developments

8.14 Regeneron Pharmaceuticals

8.14.1 Company Snapshot

8.14.2 Product/Service Offered

8.14.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.14.4 Recent Developments

8.15 STAAR Surgical

8.15.1 Company Snapshot

8.15.2 Product/Service Offered

8.15.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.15.4 Recent Developments

8.16 Takeda

8.16.1 Company Snapshot

8.16.2 Product/Service Offered

8.16.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.16.4 Recent Developments

8.17 Topcon

8.17.1 Company Snapshot

8.17.2 Product/Service Offered

8.17.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.17.4 Recent Developments

8.18 Topcon

8.18.1 Company Snapshot

8.18.2 Product/Service Offered

8.18.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.18.4 Recent Developments

8.19 NIDEK

8.19.1 Company Snapshot

8.19.2 Product/Service Offered

8.19.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.19.4 Recent Developments

8.20 Santen Pharmaceutical

8.20.1 Company Snapshot

8.20.2 Product/Service Offered

8.20.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.20.4 Recent Developments

8.21 Sun Pharmaceutical Industries

8.21.1 Company Snapshot

8.21.2 Product/Service Offered

8.21.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.21.4 Recent Developments

8.22 Others

8.22.1 Company Snapshot

8.22.2 Product/Service Offered

8.22.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.22.4 Recent Developments

Chapter 9 Upstream and Downstream Analysis of Ophthalmic Devices & Drugs

9.1 Industrial Chain of Ophthalmic Devices & Drugs

9.2 Upstream of Ophthalmic Devices & Drugs

9.2.1 Raw Materials (If Applicable)

9.2.2 Manufacturing Cost Structure (If Applicable)

9.2.3 Manufacturing Process (If Applicable)

9.3 Downstream of Ophthalmic Devices & Drugs

9.3.1 Leading Distributors/Dealers of Ophthalmic Devices & Drugs

9.3.2 Leading Consumers of Ophthalmic Devices & Drugs

Chapter 10. Global Ophthalmic Devices & Drugs Market Industry Analysis

10.1. Porter's Five Forces Analysis

10.1.1. Threat of New Entrants

10.1.2. Bargaining Power of Buyers/Consumers

10.1.3. Bargaining Power of Suppliers

10.1.4. Threat of Substitute Types

10.1.5. Intensity of Competitive Rivalry

10.2. Major Growth Avenues within Global Ophthalmic Devices & Drugs Market

10.2.1. Product Types

10.2.2. Applications

10.2.3. Sales Channels

10.2.4. Country

10.3. Ophthalmic Devices & Drugs Industry Ecosystem

10.4. Price Trend Analysis (If Applicable)

10.5. Buying Criteria (If Applicable)

10.6. Regulations (If Applicable)

Chapter 11 Development Trend of Ophthalmic Devices & Drugs (2026-2032)

11.1 Global Ophthalmic Devices & Drugs Market Size (Sales and Revenue) Forecast (2026-2032)

11.2 Global Ophthalmic Devices & Drugs Market Size and CAGR Forecast by Region (2026-2032)

11.3 Global Ophthalmic Devices & Drugs Market Size and CAGR Forecast by Type (2026-2032)

11.4 Global Ophthalmic Devices & Drugs Market Size and CAGR Forecast by Application (2026-2032)

11.5 Global Ophthalmic Devices & Drugs Market Size and CAGR Forecast by Sales Channel (2026-2032)

Chapter 12. Import - Export Analysis (If Applicable)

12.1 North America Ophthalmic Devices & Drugs Import-Export (2019-2025)

12.2 Europe Ophthalmic Devices & Drugs Import-Export (2019-2025)

12.3 Asia Pacific Ophthalmic Devices & Drugs Import-Export (2019-2025)

12.4 South America Ophthalmic Devices & Drugs Import-Export (2019-2025)

12.5 Middle East & Africa Ophthalmic Devices & Drugs Import-Export (2019-2025)

Chapter 13. Demand-Supply Gap Analysis

13.1 North America Ophthalmic Devices & Drugs Demand-Supply (2019-2025)

13.2 Europe Ophthalmic Devices & Drugs Demand-Supply (2019-2025)

13.3 Asia Pacific Ophthalmic Devices & Drugs Demand-Supply (2019-2025)

13.4 South America Ophthalmic Devices & Drugs Demand-Supply (2019-2025)

13.5 Middle East & Africa Ophthalmic Devices & Drugs Demand-Supply (2019-2025)

Chapter 14 Appendix

14.1 Research Methodology

14.2 Data Sources